Clinical Trial Update: Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a peptide-based vaccine designed to elicit T cell responses in patients with breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Craig L Slingluff, Jr | Conditions: Breast Neoplasms | Phase 1 | Status: COMPLETED